pCDH-puro-Bcl2 Citations (8)

Originally described in: Inhibition of BET bromodomain targets genetically diverse glioblastoma.
Cheng Z, Gong Y, Ma Y, Lu K, Lu X, Pierce LA, Thompson RC, Muller S, Knapp S, Wang J Clin Cancer Res. 2013 Apr 1;19(7):1748-59. doi: 10.1158/1078-0432.CCR-12-3066. Epub 2013 Feb 12. PubMed Journal

---

Articles Citing pCDH-puro-Bcl2

Showing 1 to 8 of 8 entries

Show 102550100All entries

Search table:

• Previous
• 1
• Next

Articles
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer. Nardi F, Perurena N, Schade AE, Li ZH, Ngo K, Ivanova EV, Saldanha A, Li C, Gokhale PC, Hata AN, Barbie DA, Paweletz CP, Janne PA, Cichowski K. J Clin Invest. 2023 Aug 15;133(16):e167651. doi: 10.1172/JCI167651. PubMed
Bcl-xL is required to protect endothelial cells latently infected with KSHV from virus induced intrinsic apoptosis. Moore LN, Holmes DL, Sharma A, Landazuri Vinueza J, Lagunoff M. PLoS Pathog. 2023 May 10;19(5):e1011385. doi: 10.1371/journal.ppat.1011385. eCollection 2023 May. PubMed
Quantifying requirements for mitochondrial apoptosis in CAR T killing of cancer cells. Pourzia AL, Olson ML, Bailey SR, Boroughs AC, Aryal A, Ryan J, Maus MV, Letai A. Cell Death Dis. 2023 Apr 13;14(4):267. doi: 10.1038/s41419-023-05727-x. PubMed
Tubulin Carboxypeptidase Activity Promotes Focal Gelatin Degradation in Breast Tumor Cells and Induces Apoptosis in Breast Epithelial Cells That Is Overcome by Oncogenic Signaling. Mathias TJ, Ju JA, Lee RM, Thompson KN, Mull ML, Annis DA, Chang KT, Ory EC, Stemberger MB, Hotta T, Ohi R, Vitolo MI, Moutin MJ, Martin SS. Cancers (Basel). 2022 Mar 28;14(7). pii: cancers14071707. doi: 10.3390/cancers14071707. PubMed
Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer. Yin L, Zeng Y, Zeng R, Chen Y, Wang TL, Rodabaugh KJ, Yu F, Natarajan A, Karpf AR, Dong J. Oncogene. 2021 Dec;40(50):6772-6785. doi: 10.1038/s41388-021-02117-5. Epub 2021 Nov 19. PubMed
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells. Larrue C, Guiraud N, Mouchel PL, Dubois M, Farge T, Gotanegre M, Bosc C, Saland E, Nicolau-Travers ML, Sabatier M, Serhan N, Sahal A, Boet E, Mouche S, Heydt Q, Aroua N, Stuani L, Kaoma T, Angenendt L, Mikesch JH, Schliemann C, Vergez F, Tamburini J, Recher C, Sarry JE. Nat Commun. 2021 Jan 18;12(1):422. doi: 10.1038/s41467-020-20717-9. PubMed
An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance. Bester AC, Lee JD, Chavez A, Lee YR, Nachmani D, Vora S, Victor J, Sauvageau M, Monteleone E, Rinn JL, Provero P, Church GM, Clohessy JG, Pandolfi PP. Cell. 2018 Apr 19;173(3):649-664.e20. doi: 10.1016/j.cell.2018.03.052. PubMed
Mitochondrial damage elicits a TCDD-inducible poly(ADP-ribose) polymerase-mediated antiviral response. Kozaki T, Komano J, Kanbayashi D, Takahama M, Misawa T, Satoh T, Takeuchi O, Kawai T, Shimizu S, Matsuura Y, Akira S, Saitoh T. Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2681-2686. doi: 10.1073/pnas.1621508114. Epub 2017 Feb 17. PubMed

If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.